Home Blog Page 147

Huawei He Tingbo Named to TIME’S Fourth Annual List of The TIME100 AI 

By
Advertorial Desk
-


SHENZHEN, CHINA – Media OutReach Newswire – 28 August 2026 – TIME named He Tingbo, President of HiSilicon, Huawei’s semiconductor division, to the 2026 TIME100 AI, a list recognizing the 100 most influential people in artificial intelligence.

He Tingbo, President of HiSilicon, named to TIME100 AI list.

In May 2026, He Tingbo unveiled the “Tau (τ) Scaling Law” at the IEEE International Symposium on Circuits and Systems in Shanghai: a proposal to replace the geometric shrinking of Moore’s Law with time-based scaling as the guiding principle for semiconductors and the electronic systems built on them. In the past decade under her leadership, the company has built its competitive edge in AI computing including Ascend AI accelerators, Kunpeng server processors, and UnifiedBus-enabled SuperPoD systems.

To assemble the list, TIME’s editors and reporters examined the key stories in AI over the past year and consulted with expert sources and industry leaders for recommendations. The result is a list of 100 leaders, innovators, shapers, and thinkers who have a stake in the future of AI.

See He Tingbo’s story here: https://time.com/collection/time100-ai/2026/he-tingbo/

See the full list here: http://ti.me/100ai

Hashtag: #Huawei #TIME100AI

The issuer is solely responsible for the content of this announcement.

Laos Signs Deal for 330MW Coal Power Plant in Xieng Khouang

By
Phoudasack Vongsay
-
the 330MW coal-fired power plant
A picture of signing ceremony of the 330MW coal-fired power plant for Xieng Khouang Province in northern Laos on 26 August 2026 (Photo by Vientiane Times)

A new 330-megawatt (MW) coal-fired power plant planned for Xieng Khouang Province is expected to significantly improve domestic electricity reliability for northern Laos, especially during the dry season (March to August) when river levels plummet.

On 26 August, private developer B Rich Namphan Power Sole Co., Ltd. signed a contract for the construction of the USD 202.95 million facility, which is scheduled for completion by 2029.

China Western Power Industrial Co., Ltd. will supply the equipment and supervise installation, while Dongdok Construction and Installation Engineering Sole Co., Ltd. will serve as the primary contractor.

First conceptualized during a feasibility study in 2015, the project has secured a suitable site and a local coal supply expected to last at least 25 years. The plant will operate as a domestic Independent Power Producer (IPP-D), selling its output to the state utility, Électricité du Laos (EDL), to supply small and medium-sized industries in the northern region.

The developer confirmed that the plant will be the first coal-fired project in Laos to utilize supercritical technology, providing a cleaner, highly efficient thermal baseline.

Also, because the plant’s USD 202.95 million cost is below the USD 300 million threshold set by the Lao Law, it bypasses the need for National Assembly approval.

Laos Looks Beyond Hydropower

Laos is expanding renewable energy beyond its hydropower, which currently accounts for around 70 percent of the country’s electricity generation capacity.

In recent months, authorities have advanced solar projects, including a 1,000-megawatt solar project in Oudomxay and a new 5-megawatt project in Champasak. The projects are expected to diversify electricity supplies, improve grid stability, and strengthen Laos’ role in regional energy markets.

Laos is also promoting household rooftop solar, with Electricité du Laos purchasing surplus electricity under 10-year contracts to increase domestic generation and reduce electricity imports during periods of high demand.

Meanwhile, Laos and Russia agreed in June to begin preliminary studies for a potential nuclear power plant. The initial studies will examine possible locations and how a future plant could be integrated into Laos’ energy system.

HKPC Launches “AI for All” Inclusive Programme

By
Advertorial Desk
-

Empowering SMEs and Working Professionals to Embrace AI and Foster Widespread AI Adoption in Hong Kong


HONG KONG SAR – Media OutReach Newswire – 28 August 2026 – The Hong Kong Productivity Council (HKPC) today held the Launching Ceremony of the “AI for All” Inclusive Programme, aligning with the National 15th Five-Year Plan and the “AI+” initiative, and supporting the HKSAR Government’s policies of “industries for AI, AI for industries” and “AI for All”. Coordinated by the Innovation, Technology and Industry Bureau (ITIB), the “AI for All” Inclusive Programme aims to promote the widespread adoption of AI across society. As one of the programme implementation partners, HKPC will lead the “AI with HKPC – Business Empowerment” sub-programme, focusing on practical business applications, talent development, and inclusive technology adoption. The initiative will provide targeted support to SMEs, professionals, labour groups, and underprivileged communities through a range of training courses, hands-on application programmes, and industry-academia-research collaboration, promoting AI literacy and the practical deployment of AI technologies.

Professor SUN Dong, JP, Secretary for Innovation, Technology and Industry, officiated at the ceremony, joined by Mr Emil YU Chen-on, BBS, JP, Deputy Chairman of HKPC, and Mr Mohamed Butt, MH, Executive Director of HKPC. The event also brought together representatives from leading international and Chinese Mainland technology enterprises, chambers of commerce, and industry leaders, who shared successful case studies and practical insights, fostering collaboration across sectors to advance Hong Kong’s AI ecosystem.

Professor SUN Dong, JP, Secretary for Innovation, Technology and Industry, said: “AI has become a key factor in global industrial upgrading and driving the development of the digital economy. Helping SMEs to achieve digital transformation and enhance competitiveness through AI is one of the focal points of the ‘AI for All’ inclusive programme. This time, HKPC as the third implementing organisation for the ‘AI for All’ inclusive programme, leverages its years of experience serving businesses to provide targeted and professional support to SMEs, helping them seize opportunities in the AI era. I hope that through the ‘AI for All’ inclusive programme, AI will not only serve as an empowering tool to enhance corporate value and competitiveness but also transform into a super dividend that benefits SMEs and the general public. Let ‘AI for All’ become Hong Kong’s vision for ‘Upgrading for All’ and ‘Opportunities for All’.”

Mr Emil YU Chen-on, BBS, JP, Deputy Chairman of HKPC, said: “AI should not be a privilege reserved for large enterprises. It should become a productivity tool that every business, every employee, and people from all walks of life can leverage. HKPC has long been committed to helping enterprises, particularly SMEs, enhance productivity, drive digital transformation, and convert innovative technologies into tangible business value. We focus on integrating AI technologies across different industries by providing practical, scalable and replicable solutions that support smart transformation. As one of the implementation organisations of the ‘AI for All’ Inclusive Programme, HKPC will centre its efforts on ‘AI with HKPC – Business Empowerment’, connecting Government, industry, academia, technology partners and social service organisations to help enterprises, SMEs, professionals and underprivileged communities acquire AI capabilities and transform AI into real productivity and business value, thereby advancing Hong Kong’s high-quality development and digital inclusion.”

“AI for All” Officially Launches with “Business Empowerment” Series to Drive Widespread AI Adoption

To advance the “AI for All” Inclusive Programme, HKPC has launched the “AI with HKPC – Business Empowerment” training series, centred on practical business applications. Through a two-year training and promotion programme, HKPC will work with technology companies, chambers of commerce, labour groups and community partners to help SMEs, professionals, working individuals, labour organisations, underprivileged groups and the general public acquire AI knowledge and application skills. The initiative aims to accelerate the adoption of AI and support digital and smart transformation across industries, sectors and communities through three key focus areas:

1. Business and Industry Upgrading: Through AI-focused programmes such as “AI+ Industry Boost Training” and “SME AI Connect”, enterprises can rapidly adopt AI technologies to enhance productivity and competitiveness. Key training topics include:

  • Practical Applications of Generative AI: Learning how to use generative AI tools for content creation, data analysis, and workflow optimisation.
  • AI Applications Across Industries: Exploring how AI enhances efficiency, optimises operations and drives innovation in sectors including education, healthcare, manufacturing, retail and logistics.
  • AI Project Workshops: Providing hands-on experience in AI application development and implementation, enabling participants to integrate AI solutions into real business scenarios.

2. Human Resources and Leadership: HKPC will continue conducting the “Hong Kong Enterprise AI Application Trends Survey” and share insights through “AI Talent Winning Tips”, helping organisations understand AI talent management and application trends while preparing for future workforce needs. Key topics include:

  • AI and Career Development: Examining the impact of AI on the future workplace and helping professionals understand emerging skills requirements.
  • AI Talent Management and Application Strategies: Sharing successful corporate experiences and practical strategies for AI transformation and talent development.

3. AI for ALL: Through the free online learning platform “AI BiteClass”, HKPC will provide convenient AI learning resources for SMEs, professionals, senior citizens and underprivileged communities, enabling people from all backgrounds to access AI fundamentals and the latest application trends anytime, anywhere. Key topics include:

  • Introduction to AI Fundamentals: Covering basic AI concepts, operating principles, common use cases and future trends.
  • Getting Started with Generative AI: Introducing generative AI tools and their everyday applications.
  • AI Ethics and Responsible Use: Building awareness of responsible AI adoption, including issues relating to data privacy, bias and transparency.


“AI BiteClass” Debuts at Launch Ceremony, Bringing Global Technology Expertise to Hong Kong

As part of the launch event, HKPC presented a live edition of the “AI BiteClass”, featuring experts from HKPC and leading global technology companies, including Amazon Web Services (AWS), Google Cloud, Huawei Cloud, Lenovo, Samsung, Tencent Cloud and Microsoft. The sessions shared practical AI techniques and real-world application cases tailored for SMEs. Through concise yet insightful presentations, the guest speakers highlighted the best practices and implementation strategies for AI, demonstrating how businesses can leverage AI to drive growth and enhance operational efficiency.

Looking ahead, the “AI BiteClass” will introduce a range of free online courses covering popular topics such as generative AI, AI agents, workflow automation, data analytics and enterprise transformation. Members of the public will be able to access practical AI learning resources at any time through the online platform or via iAM Smart.

HKPC has long positioned itself as a “technology adopter and enabler”, committed to helping enterprises transform innovation into tangible business value. Since 2024, HKPC has organised more than 600 AI training sessions, serving over 32,000 participants, including SMEs, large enterprises, HR professionals, industry leaders, students, educators and members of the public. These efforts have played a pivotal role in fostering a more competitive AI application ecosystem in Hong Kong.

A series of “AI with HKPC – Business Empowerment” activities will be rolled out progressively. Enterprises and members of the public are welcome to register via iAM Smart and stay updated on the latest programmes. Through collaboration with global technology enterprises, industry organisations and community partners, HKPC aims to bring AI into businesses, workplaces and communities, advancing the vision of “AI for All” while empowering enterprises and co-building Hong Kong’s intelligent future. For details, please visit: https://www.hkpcacademy.org/en/aiforall/

Please download the high-res photos HERE.

Photo Captions:

  1. Professor SUN Dong, JP, Secretary for Innovation, Technology and Industry of the HKSAR Government, delivers a speech at the ceremony, sharing the Government’s vision for advancing the “AI for All” Inclusive Programme, accelerating AI adoption and fostering innovation and technology development in Hong Kong.
  2. Professor SUN Dong, JP, Secretary for Innovation, Technology and Industry of the HKSAR Government (middle), Mr Emil YU Chen-on, BBS, JP, Deputy Chairman of HKPC (left), and Mr Mohamed Butt, MH, Executive Director of HKPC (right) officiate the HKPC Launching Ceremony of the “AI for All” Inclusive Programme, jointly promoting AI literacy and application.
  3. Mr Emil YU Chen-on, BBS, JP, Deputy Chairman of HKPC, says HKPC will help enterprises and talent master AI technologies through the “AI with HKPC – Business Empowerment” series, supporting the transition from AI awareness to practical application.
  4. The “AI for All” Inclusive Programme attracts representatives from the business and innovation and technology sectors to explore the latest AI developments and application opportunities.
  5. HKPC hosts an “AI BiteClass” sharing session on the day of the Launching Ceremony, inviting technology companies and industry experts to present practical AI experiences and success stories, helping enterprises enhance productivity and competitiveness through AI.

Hashtag: #HKPC

The issuer is solely responsible for the content of this announcement.

About the Hong Kong Productivity Council

The Hong Kong Productivity Council (HKPC) is a statutory body established in 1967, dedicated to enhancing the productivity and competitiveness of Hong Kong enterprises through world-class applied R&D, innovative technology services, and integrated manufacturing solutions. As a market-oriented, international R&D organisation, HKPC leverages its deep expertise and extensive industry experience in key areas such as AI, advanced manufacturing, life and health technology, green technology and new energy to drive new industrialisation and support the growth of emerging and future industries.

HKPC focuses on addressing businesses challenges and industrial technology needs, promoting the full integration between technological and industrial innovation. Through technology transfer, product innovation, intellectual property protection and commercialisation of R&D outcomes, the Council fosters collaboration with the local business community as well as top global R&D institutions, delivering added value to industries and advancing the development of new productive forces. HKPC’s world-class R&D achievements have been widely recognised over the years, winning an array of local and overseas accolades, reinforcing Hong Kong’s role as an international innovation and technology centre and a smart city.

To help enterprises capitalise on Hong Kong’s strengths in international connectivity to expand into global markets, HKPC offers comprehensive overseas expansion services tailored to critical areas including product development, technology, manufacturing, and management, enabling businesses to successfully go global from Hong Kong.

HKPC is also committed to providing timely and practical support to SMEs and startups with timely and practical , assisting them in accessing Government funding programmes. Through its FutureSkills training initiatives, HKPC helps both industry and academia stay ahead in latest digital and STEM technologies, nurturing a future-ready talent pool for Hong Kong.

For more information, please visit HKPC’s website: .

Alibaba’s Amap Introduces ABot-Recon, Reconstructing 10,000-Frame-Scale 3D Scenes From Just 12 Frames in Real Time

By
Advertorial Desk
-

BEIJING, Aug. 28, 2026 /PRNewswire/ — Amap, Alibaba’s location-based services platform, today released ABot-Recon, a streaming 3D reconstruction model that requires only 12 consecutive frames to reconstruct scenes spanning over 10,000 frames in real time, eliminating the need for long-range memory.

The model achieves state-of-the-art accuracy on multiple public benchmarks — including KITTI, Oxford Spires and VBR — while reducing peak memory usage to roughly one-third that of comparable methods, making real-time 3D reconstruction feasible on consumer-grade hardware.


As autonomous driving and embodied AI systems move into open environments, they require continuous spatial understanding while in motion — knowing where they are, what surrounds them and where to go next. Conventional streaming 3D reconstruction systems maintain memory anchors that store and fuse historical information to preserve global consistency. As input sequences grow longer, such systems become progressively slower, less accurate and more memory-intensive.

ABot-Recon takes a fundamentally different approach. Rather than maintaining long-range memory anchors, the model operates within a fixed 12-frame local context window, predicting only the local point cloud and the relative pose between adjacent frames. An online composition mechanism then assembles the complete global trajectory incrementally, keeping computational complexity constant regardless of sequence length.

To address drift inherent in local prediction, ABot-Recon incorporates dedicated correction and constraint mechanisms at both the prediction and training stages, calibrating trajectory error in real time.

On the Oxford Spires long-sequence benchmark, ABot-Recon reduces average trajectory error by 40.6% compared with the prior leading method, achieving a relative rotation error (RPE-R) of 0.12 degrees — approximately 40% lower than the previous state of the art. On KITTI-02, the model achieves real-time reconstruction at 24.45 FPS, 1.24 times the speed of existing approaches, with peak memory usage of approximately 6.71 GB — meaning a consumer-grade GTX 1080 Ti is sufficient to run the full pipeline.

The model requires only monocular RGB video as input, and needs no depth sensors or pre-calibrated camera parameters. This positions ABot-Recon for deployment across private-area mapping, embodied AI training, autonomous driving and 3D content production — scenarios where pre-built maps are unavailable and real-time reconstruction is essential.

ABot-Recon’s inference code, evaluation scripts and pre-trained weights are now open-sourced on GitHub. The project page is accessible at https://amap-cvlab.github.io/ABot-Recon-html/.

“Siam Paragon Bangkok Watch Week 2026” Elevates Bangkok as a Global Watch Destination

By
Advertorial Desk
-

Bringing Together More Than 45 Leading Watch Brands to Celebrate Watch Culture
Through The Symposium, Featuring Influential Voices from the World of Horology and
Discover Exclusive Exhibitions and Showcases from 22–27 September 2026 at Siam Paragon

BANGKOK, THAILAND – Media OutReach Newswire – 28 August 2026 – Siam Paragon, reaffirming its position as a global landmark and one of the world’s premier Global Luxury Destinations, is set to host a defining landmark of haute horology with the second edition of “Siam Paragon Bangkok Watch Week 2026.” The event is a ‘Celebration of Watch Culture,” bringing new depth and perspective to the world of horology through an exceptional gathering of more than 45 prestigious international watch maisons, renowned industry leaders, discerning collectors, and passionate enthusiasts from across the globe.

แนวนอน KV 1920x1080

Designed as a dynamic platform for sharing and discovery, The event will feature The Symposium, an engaging forum of conversations with leading voices in horology, alongside exclusive exhibitions and curated showcases that offer visitors an intimate encounter with exceptional timepieces and the latest innovations in watchmaking. Siam Paragon Bangkok Watch Week 2026 will take place from 22–27 September 2026 at Siam Paragon, with a vision to position Bangkok as a Global Watch Destination and one of Asia’s most significant destinations for watch culture.

Entering its second year, Siam Paragon Bangkok Watch Week 2026 welcomes more than 45 prestigious watch brands, including A. LANGE & SOHNE, BIANCHET, BOUCHERON, BREITLING, BVLGARI, CARTIER, CHOPARD, FRANCK MULLER, GRAND SEIKO, HUBLOT, IWC SCHAFFHAUSEN, JAEGER-LECOULTRE, LOUIS ERARD, PANERAI, PIAGET, TAG HEUER, TIFFANY & CO., ULYSSE NARDIN, VACHERON CONSTANTIN, and ZENITH.

The 2026 edition also welcomes a distinguished line-up of new participating brands, including AMIDA, BEHRENS, BLANCPAIN, BREGUET, BREMONT, CVSTOS, DAVID CANDAUX, GERALD CHARLES, GIRARD-PERREGAUX, GREUBEL FORSEY, JACOB & CO., L.LEROY, MB&F, NORQAIN, OMEGA, ORIS, PARMIGIANI FLEURIER, RESSENCE, ROGER DUBUIS, SPEAKE-MARIN, TUDOR, and UNIVERSAL GENEVE.

The event will further enrich engagement within the global watch community through The Symposium, a distinguished platform dedicated to the exchange of knowledge, expertise, and the stories behind the art of watchmaking. Bringing together international brand executives, master watchmakers, renowned collectors, and influential industry figures. In a significant milestone for the event, Siam Paragon Bangkok Watch Week 2026 is honored to welcome the Fondation Haute Horlogerie (FHH), the world’s leading authority on horological culture, to co-host a special edition of The Symposium.

The celebration will also feature an impressive lineup of novelties, Southeast Asia’s debuts, and world premieres from some of the industry’s most prestigious watch maisons and independent watchmakers. Reflecting its rapid ascent on the global horological calendar, this year’s Bangkok Watch Week has more than doubled the participation of leading international brands, bringing together an unprecedented spectrum of revered watch maisons and acclaimed independent creators. Siam Paragon Bangkok Watch Week 2026 aims to further establish Bangkok as a leading Global Watch Destination.

  • World Premieres and the Latest Innovations in Fine Watchmaking

One of the most anticipated highlights of Siam Paragon Bangkok Watch Week 2026 will be the unveiling of significant new timepieces and collections from more than 45 leading international watch brands. Showcasing over 200 exceptional novelties valued at hundreds of millions of baht, the event reflects strong confidence in Bangkok and the growing influence of the global collector community.

Among the standouts, Roger Dubuis will present the global debut of its iconic Knights of the Roundtable collection, offering watch enthusiasts a bold expression of creativity and mechanical mastery. Universal Genève will also make its highly anticipated Southeast Asian debut, providing a rare opportunity for the region’s watch community to experience the next chapter of the legendary Swiss watchmaker.

Collectors and enthusiasts can also explore The Exhibition, a dedicated showcase of the latest releases, limited editions, horological masterpieces, grand complications, rare treasures, and exceptional collections, offering an up-close encounter with some of the finest creations in contemporary watchmaking.

  • The Symposium: Shaping the future of horology through dialogue and discovery by leading global voices

At the heart of Siam Paragon Bangkok Watch Week 2026 is “The Symposium,” conceived as a platform for storytelling and meaningful dialogue surrounding the art and science of watchmaking. Through the perspectives of brand founders, senior executives, watchmakers, creators, and influential figures from the world of haute horlogerie,

This year, The Symposium has been expanded in both the number of sessions and the capacity of its dedicated space, enabling an even wider community of collectors and enthusiasts to participate in these exclusive conversations, with a total of 18 sessions taking place throughout the event.

Among the most anticipated speakers is Mr.Georges Kern, Group CEO of Breitling, a leading figure in the Swiss watch industry, who will share his perspectives on the future direction of the industry and his vision for building a watch brand that remains meaningfully connected with audiences in the modern world during The Symposium on The Breitling Journey- Georges Kern, on Brand Legacy, Community and the Future of Watch Culture.

Also taking part is Mr. Emmanuel Breguet, Vice President and Head of Patrimony, who will share insights into the history of Breguet and the maison’s legacy of innovation surrounding the Tourbillon, commemorating the 225th Anniversary of the Tourbillon. His participation offers collectors and horology enthusiasts a rare opportunity to hear directly from an individual with a profound connection to the maison’s heritage.

Throughout the six-day programme, The Symposium will feature a distinguished line-up of sessions, including:

  • The Symposium on CVSTOS: Beyond Tradition – Material Innovation in Modern Watchmaking with Sassoun Sirmakes – CEO
  • The Symposium on Piaget with Pierre Guerrier – Business Developer and Watchmaking Expert
  • The Symposium on Universal Genève Returns: The Beginning of A New Era for Le Couturier De La Montre with House of Brands CEO Georges Kern and Universal Genève Managing Director Gregory Bruttin
  • The Symposium on Vacheron Constantin with Morgan Maillard – Style and Heritage Expert
  • The Symposium on Franck Muller with Nicolas Rudaz – CEO
  • The Symposium on Roger Dubuis: Astronomy Meets Geneva Watchmaking Excellence-Introducing the Excalibur Biretrograde Perpetual Calendar with Jean-Philippe Bonneau, Chief Marketing Officer
  • The Symposium on Jacob & Co. Inheriting the Impossible with Benjamin Arabov – CEO
  • The Symposium on Grand Seiko: The Evolution of Precision with Takashi Sakamoto – Vice President & Jonathan Bues – Communications and Brand Advisor
  • The Symposium on TUDOR: A Century of TUDOR with Cole Pennington
  • The Symposium on Gerald Charles with Federico Ziviani – CEO
  • The Symposium on Bvlgari: The Art of Time with Emma Behaeghel – Regional Managing Director, Bulgari South Asia Pacific
  • The Symposium on Norqain with Tobias Küffer – Vice President

The programme will also feature the Watch Collector Symposium, creating a dedicated platform for collectors to exchange perspectives, experiences, and insights. Further enhancing the programme, the Fondation Haute Horlogerie (FHH) will join the event to present an exclusive Symposium programme, making The Symposium a unique platform that connects people with the stories behind watchmaking, from creative concepts and craftsmanship to the heritage of individual maisons and perspectives on the future of haute horlogerie.

  • A World-Class Experience Making Its Southeast Asian Debut

Beyond exhibitions and conversations, Siam Paragon Bangkok Watch Week 2026 will offer visitors an immersive experience through “The Experience,” a dedicated experience showcasing distinctive innovations and specially curated activities from participating watch brands.

A key highlight will be the official Southeast Asian debut of the “Academy Lounge” by Fondation Haute Horlogerie Academy (FHH Academy). For collectors, brand executives, industry professionals, and individuals with a passion for horology, the Academy Lounge will provide access to expert guidance and educational resources from the Fondation Haute Horlogerie (FHH), a globally recognized organization dedicated to advancing knowledge, preserving the cultural heritage of fine watchmaking, and promoting international standards of understanding and appreciation for haute horlogerie.

Visitors will have the opportunity to deepen their knowledge of horology through a structured learning experience and take part in assessments leading to the FHH Certification, an internationally recognized certification that reflects an established standard of knowledge in fine watchmaking.

The Experience will also feature a diverse range of exclusive activities presented by leading watch brands, offering visitors the opportunity to explore horology through multiple dimensions, including craftsmanship, creativity, technical innovation, and design, through experiences created exclusively for Siam Paragon Bangkok Watch Week 2026.

By creating an unprecedented horological phenomenon across all dimensions, encompassing insightful dialogues on watchmaking culture, immersive exhibitions, and exclusive showcases, Siam Paragon Bangkok Watch Week 2026 is not merely a venue where brands and collectors meet. Instead, it serves as a premier Watch Culture Platform that unites people, knowledge, craftsmanship, cultural heritage, and the future vision of the horological world. It stands as a celebration of the science, art, craftsmanship, and enduring legacy of watchmaking, driven by the ultimate mission to elevate Bangkok into the epicenter of watch culture in Asia and a landmark destination on the global horology calendar.

Siam Paragon Bangkok Watch Week 2026 will take place from 22–27 September 2026 at Siam Paragon, bringing together the world of fine watchmaking in a celebration designed to position Bangkok firmly on the global horological map as a Global Watch Destination.

For further information, event updates, and registration, please visit www.bangkokwatchweek.com or follow Instagram: @bangkokwatchweek.

Hashtag: #BangkokWatchWeek2026 #SIAMPIWAT #SiamParagon #SiamParagonBangkokWatchWeek2026 #LuxuryWatchDestination

The issuer is solely responsible for the content of this announcement.

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio’s DUPAC Novel-Payload Platform

By
Advertorial Desk
-
  • Collaboration leverages DualityBio’s proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and global commercialization
  • DUPAC, one of the DualityBio’s four proprietary ADC technology platforms, comprises multiple payloads with novel mechanism of action designed to address resistance to the payload classes underlying currently approved ADCs
  • DualityBio to receive a US$45 million upfront payment, more than US$1 billion in potential milestone payments, and tiered royalties on net sales

SHANGHAI, Aug. 28, 2026 /PRNewswire/ — DUALITYBIO Inc. (HKEX: 09606; “DualityBio” or the “Company”) today announced that it has entered into a collaboration and license agreement with Genentech, a member of the Roche Group, to develop next-generation antibody-drug conjugates (“ADCs”) built on the Company’s proprietary DualityBio Unique Payload Antibody Conjugate (“DUPAC”) platform.

DUPAC is one of DualityBio’s four proprietary ADC platforms and is dedicated to payloads with novel mechanisms of action. It comprises multiple distinct payloads, each built on a unique antitumor mechanism, paired with optimized and compatible linker technologies designed for systemic stability and tumor-specific release. DUPAC payloads are engineered based on a common set of criteria: high potency, broad-spectrum activity across tumor types, a short systemic half-life permitting rapid clearance, and a bystander effect suited to heterogeneous solid tumors.

As topoisomerase inhibitor–based ADCs move into earlier lines of therapy across major solid tumor indications, patients who progress on this payload class represent a large and growing area of unmet medical need. The DUPAC platform is designed to retain antitumor activity in that setting and in tumors that are less responsive to topoisomerase inhibitor–based ADCs.

Under the terms of the agreement, Duality will generate and develop ADCs against Genentech defined oncology targets using payloads from the DUPAC platform. For the collaboration programs, DualityBio will lead discovery and early global clinical development. Genentech receives an exclusive, worldwide license to the collaboration ADCs, and will assume sole responsibility for further clinical development and commercialization after Phase 1a.

Under the agreement, DualityBio will receive an upfront payment of US$45 million and is eligible to receive more than US$1 billion in aggregate development, regulatory and commercial milestone payments across all programs, together with tiered royalties on annual net sales of approved products.

“As topoisomerase inhibitor–based ADCs achieve broad clinical success and move into earlier lines of therapy, a growing unmet medical need is emerging for patients whose tumors are resistant or refractory to this payload class. We built DUPAC to help address this challenge with a family of next-generation payloads designed to overcome resistance and enable each ADC program to expand the breadth of the underlying tumor biology. By combining DualityBio’s payload innovation and early-stage global clinical development capabilities with Genentech’s deep oncology expertise and worldwide development reach, we can advance these programs with greater speed and scale and bring differentiated medicines to more patients around the world,” said Dr. John Zhu, Founder and Chief Executive Officer of DualityBio.

“By further enhancing targeted medicines like ADCs, we focus our innovation where the need is highest,” said Boris L. Zaïtra, head of Roche Corporate Business Development. “Backed by Roche’s decades-long legacy in oncology, collaborating with partners such as DualityBio enables us to identify novel treatment options, such that we can tackle patients’ unmet needs in cancer care.”

About DUPAC

DUPAC (DualityBio Unique Payload Antibody Conjugate) is DualityBio’s proprietary platform for ADC payloads with novel mechanisms of action, and one of four ADC technology platforms developed by the Company alongside DITAC, DIMAC and DIBAC. DUPAC encompasses several payloads, including DUP5, DUP9 and DUP10, each acting through a distinct antitumor mechanism. Preclinical data on DUP5-based ADCs and DUP9-based ADCs, including activity in tumor models relatively insensitive to topoisomerase inhibitor payloads and non-human primate tolerability, have been presented at multiple medical conferences, including AACR 2025 (Abstract 5454), AACR-NCI-EORTC International Conference 2025 (Abstract B129 and Abstract B130), and AACR 2026 (Abstract 2657).

About DualityBio

DualityBio is a clinical-stage innovative biopharmaceutical company dedicated to developing next-generation antibody-drug conjugates (ADCs) for patients with cancer and autoimmune diseases. The Company has successfully built multiple next-generation ADC technology platforms with global intellectual property rights. Grounded in a deep understanding of disease biology, DualityBio has established a robust clinical-stage ADC pipeline and is conducting multiple global, multicenter clinical trials across nearly 20 countries, with over 3,500 patients enrolled to date. Furthermore, DualityBio has entered into several out-licensing collaborations with global pharmaceutical companies and leading innovative biotech firms. Serving as a global engine for ADC innovation, DualityBio continues to develop next-generation novel ADCs, including bispecific ADCs, ADCs with novel payloads, and autoimmune ADCs.    

For more information, please visit www.dualitybiologics.com.

Forward-Looking Statements

This press release contains statements that may be deemed to be “forward-looking statements” within the meaning of applicable securities laws. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “intends,” “plans,” “believes,” “may,” and similar expressions. Statements that are not historical facts, including statements about the beliefs, plans, objectives, and expectations of Duality Biotherapeutics, Inc. (the “Company”) regarding its business, research and development programs, and product candidates, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to risks related to the Company’s research and development, clinical trials, regulatory approvals, commercialization, and general economic and industry conditions.

All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law or regulatory rules.

Singclean 2nd Leaders Summit Charts New Course in Global Aesthetics

By
Advertorial Desk
-

SHANGHAI, Aug. 28, 2026 /PRNewswire/ — Hosted within the IMCAS China Conference venue at W Shanghai – The Bund, Singclean 2nd International Medical Aesthetic Leaders Summit themed “Global Vision, Embark on a New Chapter” came to a successful conclusion.


2026 IMCAS China Singclean Highlight Video

Gathering top global doctors and industry partners, the summit built a cross-border professional dialogue platform. Experts delivered in-depth speeches on Singfiller and Singderm dermal fillers, covering injection techniques, aesthetic solutions and raw material quality control, charting pathways toward standardized and high-quality industry development.

Precision Shaping in Three Key Zones

Dr. Zhu Yuan, a leading Chinese skeletal aesthetics expert, shared precision injection strategy for comprehensive aesthetic design, focusing on shoulder reshaping, tear trough plumping and lip augmentation. She proposed an innovative combined technique to balance contour beauty and dynamic naturality.

Praising Singfiller, she noted its stable shaping, natural resilience and excellent compatibility with collagen and regenerative materials, fully meeting dynamic aesthetic needs.

Customized Plans via Four-Dimensional Assessment

Dr. Diogo Melo, a renowned Brazilian plastic surgeon, introduced full-face hyaluronic acid treatment based on a four-dimensional facial assessment of chronological stage, facial pattern, skeletal profile and treatment timeline. He emphasized abandoning stereotyped treatments and standardized phased procedures.

He affirmed that Singderm’s superior support and deformation resistance perfectly adapts to the needs of different diagnostic and treatment stages—including skeletal reconstruction, volume augmentation, and fine micro-adjustments—helping to achieve long-lasting, natural, and individualized aesthetic outcomes.

Raw-Material Excellence as Quality Foundation

Mr. Antoine Clavier-Choo, Chief Commercial Officer APAC, HTL Biotechnology-a global leader in pharma-grade biopolymers, underscored the raw material quality behind Singfiller and Singderm—drawing directly from HTL’s HA supply. Sourced from French facilities under stringent international pharmaceutical regulations, it is produced via proprietary fermentation and multi-stage purification to yield high-purity fibers.

With more than 30 years of zero batch recalls and manufacturing operations regularly audited by leading healthcare companies worldwide, HTL delivers fibers with consistent quality and reliability.

Looking Ahead

The summit marks a key milestone in Singclean’s globalization and academic development. Moving forward, Singclean will deepen global supply chain cooperation, prioritize technological innovation and clinical academia, build an open cross-border exchange platform for physicians, and deliver high-standard aesthetic services to boost the sustainable and innovative development of the global medical aesthetics industry.

Beauty Farm 1H2026 Net Profit Surges 40%, Reinforcing Its Industry Leadership

By
Advertorial Desk
-

1H2026 Performance Highlights:

  • Revenue reached RMB1.88 billion, up 29.0% year-on-year
  • Net profit reached RMB240 million, up 40.2% year-on-year
  • Gross profit margin reached 51.4%, up 2.1 percentage points year-on-year
  • Net cash flow generated from operating activities reached RMB550 million, up 34.4% year-on-year

HONG KONG, Aug. 28, 2026 /PRNewswire/ — On August 28, Beauty Farm Medical and Health Industry Inc. (02373.HK, “Beauty Farm” or the “Group”) announced its interim results for the six months ended June 30, 2026 (the “Reporting Period”). During the Reporting Period, the Group recorded revenue of RMB1.88 billion, up 29.0% year-on-year; net profit of RMB240 million, up 40.2% year-on-year; and adjusted net profit of  RMB260 million, up 39.9% year-on-year. Gross profit margin further increased to 51.4%, up 2.1 percentage points year-on-year, reflecting continued improvement in profitability.

Meanwhile, the Company continued to demonstrate a strong cash-generating profile. During the Reporting Period, net cash flow generated from operating activities amounted to RMB550 million, up 34.4% year-on-year. As of June 30, 2026, total cash and cash-like items reached RMB2.4 billion, up 21.5% year-on-year, providing a solid financial foundation for business expansion, R&D investment and shareholder returns.

“Dual Beauty + Dual Wellness” Integrated Business Model Delivers Strong Results

In the first half of 2026, the Group’s “dual beauty + dual wellness” business model delivered strong results. Beauty and wellness services generated revenue of RMB1.09 billion, up 35.7% year-on-year, while gross profit margin reached 44.2%, up 2.1 percentage points from the same period last year. The strong performance was mainly driven by increases in both client visits and average spending. During the Reporting Period, client visits at the Group’s direct beauty and wellness stores reached 1.13 million, up 33% year-on-year.

In May 2026, Beauty Farm, identified as the top brand in China’s premium beauty service sector, officially unveiled its new brand proposition, “Beauty, Beyond”, and jointly released the White Paper on Premium Lifestyle Beauty Services with Ipsos. The brand completed a comprehensive upgrade across four dimensions – core philosophy, visual identity, store service philosophy and scientific research collaboration. In the same month, the Group entered into collaborations with leading research partners, including the Shiseido China Innovation Center Shanghai Fengxian Branch and the Aging Science Innovation R&D Center (ACRDC) at the Yangtze Delta Region Institute of Tsinghua University, Zhejiang. The Center is led by Nobel laureate Professor Michael Levitt, winner of the 2013 Nobel Prize in Chemistry, as its Chief Scientific Advisor, marking Beauty Farm’s formal entry into proprietary R&D.

Siyanli, a premium tech-powered beauty brand in China, celebrated its 30th anniversary in 2026, which also marked the milestone year of its formal integration into the listed-company platform and the beginning of a new stage of high-quality development. During the Reporting Period, Siyanli’s adjusted net profit margin reached 11.0%, a marked increase from the full-year 2024 level of 9.5%, further demonstrating the Group’s strong M&A integration capabilities. Naturade, identified by Frost & Sullivan as the “Top AI-Powered Wellness Brand in China”, recorded an adjusted net profit margin of 10.8% during the Reporting Period, up 0.4 percentage points year-on-year. In August 2026, the Group announced that 10 Naturade stores in Hangzhou would be incorporated into its direct-store network, making Hangzhou a key strategic foothold for Naturade’s expansion into the Yangtze River Delta.

In the consumer healthcare segment, the Group officially launched “CellCare Meitian Medical” in August 2026, integrating its aesthetic medical and subhealth medical resources. Positioned as an “expert in beauty, health and anti-aging medicine”, CellCare Meitian Medical provides customers with one-stop beauty, health and anti-aging solutions.

CellCare delivered better-than-expected performance during the Reporting Period, with revenue reaching RMB600 million, up 20.9% year-on-year, and gross profit margin reaching 58.9%, up 2.0 percentage points year-on-year. Client visits at direct stores reached 61,000, up 23.7% year-on-year, reflecting continued strong in-store demand and the resilience of the consumer healthcare segment amid the current industry environment. Neology, the Group’s subhealth medical services brand, generated revenue of RMB180 million during the period, up 20.1% year-on-year, while gross profit margin reached 69.0%, up 6.0 percentage points year-on-year. Client visits at direct stores reached 20,000, up 8.3% year-on-year, with both volume and price increasing.

Dual Engines of Internal Growth and External Acquisitions Drive Long-Term Growth Momentum

The Group remains committed to the dual-engine strategy of “internal growth + external acquisitions”, leveraging the advantages of its listed-company platform to continue advancing consolidation across the beauty and health industry.

On the internal growth front, the Group continues to refine operating efficiency and build an industry-leading operating model through refined operations and strong middle- and back-office capabilities. During the Reporting Period, revenue per direct store at the flagship Beauty Farm brand increased by 5.5% year-on-year, setting an industry benchmark through exceptional internal operating efficiency and growth capabilities.

On the external acquisitions front, the Group leverages mature systematic capabilities to advance post-acquisition integration efficiently and unlock the full-lifecycle value of its members. Since Siyanli was formally consolidated into the Group’s financial statements in January 2026, the brand has continued to enhance its value in three key areas. First, it upgraded its premium service system by further developing the “five senses and six awarenesses” experience and expanding into premium commercial locations, reinforcing its positioning as a premium service brand. Second, the Group integrated consumer healthcare resources and leveraged Meitian Medical’s extensive clinic network to fully meet the consumer healthcare needs of Siyanli customers. Third, it advanced the integration of middle- and back-office functions by deploying modularized and productized capabilities, enabling resource sharing and synergistic efficiency gains across the supply chain, training, digitalization and other functions. During the Reporting Period, Siyanli’s adjusted net profit margin rose significantly to 11.0%, once again demonstrating the Group’s strong M&A integration capabilities.

Digital Intelligence Powers Personalized Care Maps

The Group is committed to building an enterprise that integrates digital intelligence into its operations and has continuously evolved through informatization, digitalization and intelligent transformation. Over the past decade, it has cumulatively invested more than RMB500 million and built an IT team of around 100 professionals, establishing itself as a leader in digital intelligence development in the beauty and health sector.

During the Reporting Period, the Group achieved multiple breakthroughs in digital intelligence development. In March 2026, Beauty Farm AI Skin Analysis underwent a major upgrade. Powered by extensive skin data and intelligent algorithms, the system can not only analyze customers’ current skin conditions with precision, but also use historical assessment results to predict future changes, creating a personalized and dynamically adjusted long-term care map across three dimensions – skin type, skin tone and skin age. In the first half of 2026, the Group also fully rolled out Naturade’s “AI-Powered Wellness 2.0” system, completing an end-to-end digital closed loop across the customer service journey. Built around five core modules – intelligent detection, reporting, recommendation, conditioning and feedback – the system provides each customer with personalized health and wellness plans covering the full lifecycle.

Capital Market Value Continues to Rise as Shareholder Returns Strengthen

The Company continues to enhance its capital market value by focusing on three key areas: optimizing shareholder structure, maintaining a high dividend payout ratio and implementing management incentives, thereby continuously unlocking long-term investment value. In terms of dividends, the Company has explicitly committed to a stable dividend payout ratio of no less than 50% of the net profit attributable to shareholders for the next three years. The final dividend of HK$0.72 per share for the year ended December 31, 2025 represents a 38% year-on-year increase, and went ex‑dividend on August 19, 2026. In terms of management incentives, the Group has closely linked future revenue and profit targets with equity incentives, and the first-year performance targets have already been exceeded, fully demonstrating the effectiveness of the incentive mechanism. In addition, the Group continues to conduct share buybacks, demonstrating its firm confidence in the Company’s long-term development through concrete actions.

Looking Ahead: Building on Three Core Competitive Advantages and Advancing the Three Super Strategies

In August 2026, the Group officially announced the renaming and upgrade of its group brand from “Beauty Farm Medical and Health Group” to “BFG Meitian Group”. The Group’s ability to navigate market cycles over the past 33 years is underpinned by three core competitive advantages. First, it has built a diversified premium beauty and health brand portfolio, spanning beauty and wellness and consumer healthcare, and encompassing the top three beauty service chain brands in China, with a base of 300,000 premium female customers at direct stores during the past 33 years. Second, it has established a strong nationwide store network. According to Winshang Data, the Group’s brands have a 42% coverage rate in premium commercial locations across 20 high-tier cities, approaching half. Third, the Group has developed industry-leading AI and digital-intelligence capabilities. At the front end, it has built a refined operating system based on customer segmentation, store typology and project classification; in the middle and back office, it strengthens systematic capability building to fully release economies of scale; and in M&A integration, it deploys digital-intelligence capabilities to realize the synergistic vision of “integration upon acquisition, efficiency gains upon integration”.

Looking ahead, the Group will build on these three core competitive advantages and continue to advance its Three Super Strategies to guide high-quality development over the next five years. Under Super Brand, the Group will continue to enhance product strength and service standards, create “exceptional experiences that exceed expectations”, and reshape the value proposition of the beauty industry. Under Super Chain, it aims to cultivate 20 super cities each generating more than RMB100 million in revenue, continue its global curation and dedicated R&D approach, and strengthen supply chain autonomy and control. Under Super Digitalization, it will continue to build digital intelligence and AI infrastructure and strive to become a benchmark for digital-intelligence-led beauty and health service chains.

About Beauty Farm

Beauty Farm Medical and Health Industry Inc. is a leading beauty and health management platform in China. Over the past 33 years, Beauty Farm has developed a unique “dual beauty + dual wellness” business model, covering customers’ comprehensive beauty and health needs for their entire life cycle. We offer a diversified service matrix, including beauty and wellness brands Beauty Farm, Naturade, Siyanli and Palaispa, aesthetic medical brand CellCare, and subhealth medical services brand Neology. Our nationwide store network reaches over 100 cities with over 700 stores and serves millions of mid-to-high-end customers in top-tier cities in China. Beauty Farm was successfully listed on the Main Board of the Hong Kong Stock Exchange (stock code: 02373.HK) in January 2023.

For more information, please visit https://ir.beautyfarm.com.cn/.

For investor and media inquiries, please contact:

Beauty Farm Medical and Health Industry Inc.
Vivian Lu
Tel: +86 (21) 6095-3299
Email: ir@beautyfarm.com.cn 

EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITED
Julia Liang
Tel: +852 3468 8434 
Email: Julia.liang@everbloom.com.cn 

EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITED
Yuvia Wang
Tel: +852 3468 8421
Email: Yuvia.wang@everbloom.com.cn 

1...146147148...6,607Page 147 of 6,607